CVS HEALTH Corp financials
Key figures from CVS HEALTH Corp's filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | $106.1B | $98.9B | +7.3% |
| Net income | $3.0B | $1.0B | +191.8% |
| Free cash flow | $5.7B | $1.3B | +338.3% |
| Gross margin | 44.5% | 45.4% | -0.9 pts |
| Operating margin | 4.4% | 2.4% | +2.0 pts |
| Net margin | 2.8% | 1.0% | +1.8 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $402.1B | $1.8B | 0.4% | $7.8B | $1.39 |
| FY Dec 2024 | $372.8B | $4.6B | 1.2% | $6.3B | $3.66 |
| FY Dec 2023 | $357.8B | $8.3B | 2.3% | $10.4B | $6.47 |
| FY Dec 2022 | $322.5B | $4.3B | 1.3% | $13.4B | $3.26 |
| FY Dec 2021 | $292.1B | $8.0B | 2.7% | $15.7B | $6.02 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.